CoChat

Type III hyperlipoproteinema with apolipoprotein E2/2 genotype in Japan

Open access
Eto, M, Saito, M, Nakata, H, Iwashima, Y, Watanabe, K, Ikoda, A, Kaku, K · 2002 · Clinical Genetics
Cited by 16

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Limited information is available concerning type III hyperlipoproteinemia (HLP) in the Asian population. Therefore, clinical and biochemical characteristics of type III HLP were examined in 16 Japanese patients. Mean plasma triglyceride (TG) and total cholesterol (chol) levels were 381 mg/dl and 253 mg/dl, respectively, and the mean very low density lipoprotein (VLDL)‐chol/plasma TG ratio was 0.27, which were lower than those reported in Western countries. Eighty percent of the patients had high plasma remnant‐like particles (RLP)‐chol levels above 50 mg/dl and a high RLP‐chol/plasma TG ratio above 0.1. Twelve patients (75.0%) were obese. Seven patients (43.8%) had type 2 diabetes mellitus and four patients (25.0%) had impaired glucose tolerance. Six patients (37.5%) had coronary heart disease (CHD), but none had peripheral vascular disease or xanthomas. TG‐rich lipoproteins from type III HLP patients with diabetes mellitus stimulated cholesteryl ester synthesis by human macrophages significantly (p < 0.001) more than those from type III HLP patients without diabetes mellitus. In conclusion, the Japanese type III HLP patients had lower plasma TG and total chol levels and a lower VLDL‐chol/plasma TG ratio, but CHD was more common. The patients were characterized by a high frequency of obesity and/or glucose intolerance. The TG‐rich lipoproteins from type III HLP patients with diabetes mellitus were more atherogenic.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1034/j.1399-0004.2002.610604.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 16

Metadata

Authors
Eto, M., Saito, M., Nakata, H., Iwashima, Y., Watanabe, K., Ikoda, A., & Kaku, K.
Venue
Clinical Genetics
Publisher
Wiley
Published
2002-06
Volume
61
Issue
6
Pages
416-422
ISSN
  • 0009-9163 (ISSN-L)
  • 1399-0004
OpenAlex
W1501779041
Cited by
16
References
5
FWCI
0.62
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Type III hyperlipoproteinema with apolipoprotein E2/2 genotype in Japan. https://app.cochat.ai/papers/10.1034/j.1399-0004.2002.610604.x
The paper
Eto, M., Saito, M., Nakata, H., Iwashima, Y., Watanabe, K., Ikoda, A., & Kaku, K. (2002). Type III hyperlipoproteinema with apolipoprotein E2/2 genotype in Japan. Clinical Genetics. https://doi.org/10.1034/j.1399-0004.2002.610604.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.